Total Funding
29
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 29 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
122786
Nerio Therapeutics is a biotechnology company focused on the life sciences sector.
Acquired by 
Boehringer Ingelheim
- Sergio Duron: Chief Scientific Officer
Eben Massari: Vice President, BiologyPast Role: Plexium, VP Screening and CNS
About the Company
Nerio Therapeutics is a biotechnology company focused on the life sciences sector.
It was founded in 2019 and is based in La Jolla, CA, USA.